Against this background, we conducted a pilot study to evaluate the feasibility and safety of symptom-limited CPET and 6MWT in patients with high-risk or relapsed hematologic malignancies, after ...
Haematological parameters in chronic myeloid leukaemia as determinants of clinical manifestations in this disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback